Suppr超能文献

[精神分裂症中的生物标志物]

[Biological markers in schizophrenia].

作者信息

Lembreghts M, Ansseau M

机构信息

l'Unité de Psychiatrie, C.H.U. du Sart Tilman, Liège, Belgique.

出版信息

Encephale. 1993 Sep-Oct;19(5):501-23.

PMID:8306920
Abstract

Based on a review of the literature, the article deals with the major biological markers of schizophrenia. Recent developments in molecular biology have shown a possible association between schizophrenia and various HLA markers (A1, A2, A9, A10, A28, B27, BW16), and a linkage--in several families--between the disease and some polymorphisms of chromosome 5. On the other hand, chromosome X might also be involved. Neuropathological abnormalities have often been found in the brains of schizophrenics, such as cellular alterations in the basal ganglia and the limbic structures. Investigations by means of CT-scan and Magnetic Resonance Imaging have pointed out an enlargement of cerebral ventricles and/or an atrophy of frontal areas, especially amongst patients with prominent negative symptoms. The dopaminergic hypothesis of schizophrenia reposes on the major following facts: the therapeutic efficiency of neuroleptics (dopaminergic antagonists); a positive correlation between plasma homovanillic acid (metabolite of dopamine) concentration and the severity of schizophrenic illness; a higher density of dopaminergic D2-receptors (revealed by Positron Emission Tomography thanks to specific radioligands), particularly in the striatum; and an abnormal plasmatic growth-hormone response to apomorphine (dopaminergic agonist). Central noradrenergic dysfunctions might also occur in paranoid schizophrenia, as underlined by higher cerebrospinal fluid levels of norepinephrine, and a lack of decrease of plasma 3-methoxy-4-hydroxy-phenylglycol (MHPG, metabolite of norepinephrine) after clonidine (alpha-2-adrenergic agonist) dispensation. Nevertheless, in patients with predominating negative symptoms, this is a trouble in serotoninergic functions which has been suggested. In the field of immunology, some findings such as alteration in lymphocytes populations (T4/T8, CD5), anti-cerebral auto-antibodies, abnormal lymphocytes responses to mitogens, decreased production of interleukin-2, have lead to two main hypotheses: autoimmunity and immunologic incompetence. On the other hand, electrophysiological studies have shown a hypovariability of alpha-rythm on the EEG; a lower amplitude of the component P300 from visual evoked potentials; sleep disorders such as a shorter rapid eye movement sleep latency and a decreased total slow-wave sleep percent; irregular smooth pursuit eyes-movements; an electrodermal response according to either the hyper-responder either the non-responder type. At last, troubles in sensory integration, motor coordination and attention have also been demonstrated. All those many findings outline the heterogeneity of schizophrenic disorders.

摘要

基于文献综述,本文探讨了精神分裂症的主要生物学标志物。分子生物学的最新进展表明,精神分裂症与多种人类白细胞抗原(HLA)标志物(A1、A2、A9、A10、A28、B27、BW16)之间可能存在关联,并且在一些家族中,该疾病与5号染色体的某些多态性之间存在连锁关系。另一方面,X染色体可能也与之有关。在精神分裂症患者的大脑中经常发现神经病理学异常,例如基底神经节和边缘结构的细胞改变。通过CT扫描和磁共振成像进行的研究指出,脑室扩大和/或额叶萎缩,尤其是在具有明显阴性症状的患者中。精神分裂症的多巴胺能假说是基于以下主要事实:抗精神病药物(多巴胺能拮抗剂)的治疗效果;血浆高香草酸(多巴胺的代谢产物)浓度与精神分裂症病情严重程度之间呈正相关;多巴胺能D2受体密度较高(通过正电子发射断层扫描借助特定放射性配体显示),特别是在纹状体中;以及对阿扑吗啡(多巴胺能激动剂)的血浆生长激素反应异常。偏执型精神分裂症中也可能发生中枢去甲肾上腺素能功能障碍,这一点可通过脑脊液中去甲肾上腺素水平升高以及可乐定(α-2肾上腺素能激动剂)给药后血浆3-甲氧基-4-羟基苯乙二醇(MHPG,去甲肾上腺素的代谢产物)缺乏降低来体现。然而,在以阴性症状为主的患者中,有人提出这是5-羟色胺能功能出现了问题。在免疫学领域,一些发现,如淋巴细胞群体改变(T4/T8、CD5)、抗脑自身抗体、淋巴细胞对有丝分裂原的异常反应、白细胞介素-2产生减少,引发了两个主要假说:自身免疫和免疫功能不全。另一方面,电生理学研究表明,脑电图上α节律的变异性降低;视觉诱发电位中P300成分的波幅较低;睡眠障碍,如快速眼动睡眠潜伏期缩短和总慢波睡眠百分比降低;不规则的平稳跟踪眼球运动;根据高反应者或无反应者类型出现的皮肤电反应。最后,感觉整合、运动协调和注意力方面的问题也得到了证实。所有这些众多发现都凸显了精神分裂症的异质性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验